Concepedia

Prapti A. Patel

PA

Statistics

Publications

45

Citations

2K

H-Index

22

Active since

2008

Affiliations

The University of Texas Southwestern Medical Center(Current)

The University of Texas MD Anderson Cancer Center

Memorial Sloan Kettering Cancer Center

University of Chicago

Oregon Health & Science University

Prapti A. Patel is an author at The University of Texas Southwestern Medical Center specializing in medicine, hematologic malignancy therapy, and pharmacology.

ORCID

Publications per year

2008–2025

45

Publications

45

Ivosidenib or enasidenib combined with intensive chemotherapy in patients with newly diagnosed AML: a phase 1 study

Eytan M. Stein, Courtney D. DiNardo, Amir T. Fathi et al. · Blood · 2020 · 233 citations · Full text

, , +9

Precision medicine treatment in acute myeloid leukemia using prospective genomic profiling: feasibility and preliminary efficacy of the Beat AML Master Trial

Amy Burd, Ross L. Levine, Amy S. Ruppert et al. · Nature Medicine · 2020 · 192 citations · Full text

, , +17

Mutant Isocitrate Dehydrogenase 1 Inhibitor Ivosidenib in Combination With Azacitidine for Newly Diagnosed Acute Myeloid Leukemia

Courtney D. DiNardo, Anthony S. Stein, Eytan M. Stein et al. · Journal of Clinical Oncology · 2020 · 174 citations · Full text

, , +16

Multicenter Study of Risk-Adapted Therapy With Dose-Adjusted EPOCH-R in Adults With Untreated Burkitt Lymphoma

Mark Roschewski, Kieron Dunleavy, Jeremy S. Abramson et al. · Journal of Clinical Oncology · 2020 · 150 citations · Full text

, , +17

Crenolanib besylate, a type I pan-FLT3 inhibitor, to demonstrate clinical activity in multiply relapsed FLT3-ITD and D835 AML.

Jörge E. Cortes, Hagop M. Kantarjian, Tapan M. Kadia et al. · Journal of Clinical Oncology · 2016 · 101 citations

, , +14

1–5 of 45